Glucos Viaflo Baxter

Glucos Viaflo Baxter is an intravenous solution whose active ingredient is glucose. The product is supplied without a specified strength and is intended for parenteral administration. It originates from the European Union market and is classified under the broader category of glucose solutions used in clinical settings for energy provision and fluid management.

Glucos Viaflo Baxter is used in medical practice to address several clinical needs related to glucose administration and fluid balance.

- Treatment of hypoglycemia when oral intake is not feasible. - Provision of caloric support in patients requiring parenteral nutrition. - Maintenance of blood glucose levels during surgery or intensive care. - Dilution and carrier for certain intravenous medications. - Rehydration therapy in conjunction with electrolyte replacement.

Glucos Viaflo Baxter may be associated with a range of side effects, which are generally categorized by frequency and severity.

Common: - Mild hyperglycemia. - Local irritation at the infusion site. - Nausea or vomiting. - Headache. - Transient increase in serum osmolality.

Serious: - Severe hyperglycemia leading to ketoacidosis. - Allergic reaction such as rash or urticaria. - Fluid overload causing pulmonary edema. - Electrolyte imbalance, particularly hyponatremia. - Hypotension due to rapid infusion.

When considering Glucos Viaflo Baxter, healthcare professionals should observe several precautionary measures to minimize risk.

- Assess baseline blood glucose and monitor levels regularly during infusion. - Adjust infusion rate in patients with renal or cardiac insufficiency to avoid fluid overload. - Use caution in individuals with known glucose intolerance or diabetes mellitus. - Verify compatibility with other intravenous solutions before co-administration. - Ensure proper aseptic technique to prevent infection at the infusion site. - Review patient history for any prior allergic reactions to glucose-containing products.

Glucos Viaflo Baxter can interact with other medications or clinical conditions, requiring careful management.

Avoid: - Co-administration with high-dose insulin without appropriate glucose monitoring. - Simultaneous infusion of hypertonic saline solutions that may exacerbate hyperosmolar states.

Use with caution: - Concurrent use of diuretics, which may affect fluid balance. - Administration alongside medications that influence blood glucose, such as glucocorticoids. - Patients receiving total parenteral nutrition, to avoid excessive caloric intake. - Situations involving electrolyte-altering drugs, requiring close electrolyte monitoring.